A internally controlled, single-blinded, randomized controlled trial to investigate the use of Bimatoprost eyelash gel on eyelash growth and appearance in breast cancer patients who suffer from madarosis (loss of eyelashes) due to the side effects of chemotherapy. IND and IRB approval have been obtained.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
20
Bimatoprost 0.03% solution was compounded into a gel - patients used on eyelash margin once daily placing gel with a fingertip or Q-tip for 6 months
Duke University Medical Center
Durham, North Carolina, United States
eyelash length
eyelash ruler used to measure eyelash length
Time frame: 6 months
eyelash pigment
blinded grader used digital photos to grade degree of pigment on scale of 1-5
Time frame: 6 mos
eyelash thickness
blinded grader used digital photos to grade degree of thickness on scale of 1-5
Time frame: 6 mos
eyelash amount
blinded grader used digital photos to grade degree of amount by counting lashes
Time frame: 6 mos
eyelash side effects
any side effects (irritation, allergy, iop change, visual acuity, macular edema, uveitis, iris color change, etc... were assessed
Time frame: 6 mos
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.